CH
CVI Holdings Portfolio holdings
AUM
$116M
This Quarter Return
-17.43%
1 Year Return
+3.84%
3 Year Return
+23.84%
5 Year Return
+272.82%
10 Year Return
–
AUM
$28.3M
AUM Growth
+$28.3M
(-60%)
Cap. Flow
-$36.6M
Cap. Flow
% of AUM
-129.47%
Top 10 Holdings %
Top 10 Hldgs %
80.51%
Holding
53
New
15
Increased
1
Reduced
7
Closed
16
Top Buys
| 1 |
ZGYHU
Yunhong International Unit
ZGYHU
|
$3.33M |
| 2 |
Enlivex Therapeutics
ENLV
|
$1.81M |
| 3 |
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
|
$1.21M |
| 4 |
BXRX
Baudax Bio, Inc. Common Stock
BXRX
|
$1.07M |
| 5 |
Imunon
IMNN
|
$1.03M |
Top Sells
| 1 |
Abeona Therapeutics
ABEO
|
$17.1M |
| 2 |
AMRS
Amyris Inc.
AMRS
|
$5.03M |
| 3 |
MannKind Corp
MNKD
|
$4.78M |
| 4 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$4.58M |
| 5 |
HEXO
HEXO Corp. Common Shares
HEXO
|
$3.7M |
Sector Composition
| 1 | Healthcare | 33.34% |
| 2 | Communication Services | 2.81% |
| 3 | Technology | 2.12% |
| 4 | Materials | 1.02% |
| 5 | Consumer Staples | 0.81% |
